236 related articles for article (PubMed ID: 34523187)
1. A multiple-method comparative study using GC-MS, AMDIS and in-house-built software for the detection and identification of "unknown" volatile organic compounds in breath.
Marder D; Tzanani N; Baratz A; Drug E; Prihed H; Weiss S; Ben-Chetrit E; Eichel R; Dagan S; Yishai Aviram L
J Mass Spectrom; 2021 Oct; 56(10):e4782. PubMed ID: 34523187
[TBL] [Abstract][Full Text] [Related]
2. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
[TBL] [Abstract][Full Text] [Related]
3. Exploratory study on noninvasive biomarker of silicosis in exhaled breath by solid-phase microextraction-gas chromatography-mass spectrometry analysis.
Yi Z; Dong S; Wang X; Xu M; Li Y; Xie L
Int Arch Occup Environ Health; 2023 Aug; 96(6):857-868. PubMed ID: 37067574
[TBL] [Abstract][Full Text] [Related]
4. Determination of volatile organic compounds in human breath for Helicobacter pylori detection by SPME-GC/MS.
Ulanowska A; Kowalkowski T; Hrynkiewicz K; Jackowski M; Buszewski B
Biomed Chromatogr; 2011 Mar; 25(3):391-7. PubMed ID: 21321973
[TBL] [Abstract][Full Text] [Related]
5. Breath analysis of smokers, non-smokers, and e-cigarette users.
Papaefstathiou E; Stylianou M; Andreou C; Agapiou A
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1160():122349. PubMed ID: 32920481
[TBL] [Abstract][Full Text] [Related]
6. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
7. Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry.
Buszewski B; Ulanowska A; Ligor T; Denderz N; Amann A
Biomed Chromatogr; 2009 May; 23(5):551-6. PubMed ID: 19039804
[TBL] [Abstract][Full Text] [Related]
8. Detection technologies of volatile organic compounds in the breath for cancer diagnoses.
Le T; Priefer R
Talanta; 2023 Dec; 265():124767. PubMed ID: 37327663
[TBL] [Abstract][Full Text] [Related]
9. Chromatographic analysis of VOC patterns in exhaled breath from smokers and nonsmokers.
Capone S; Tufariello M; Forleo A; Longo V; Giampetruzzi L; Radogna AV; Casino F; Siciliano P
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29131420
[TBL] [Abstract][Full Text] [Related]
10. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls.
Woollam M; Angarita-Rivera P; Siegel AP; Kalra V; Kapoor R; Agarwal M
J Breath Res; 2022 May; 16(3):. PubMed ID: 35453137
[TBL] [Abstract][Full Text] [Related]
11. Screening for volatile biomarkers of colorectal cancer by analyzing breath and fecal samples using thermal desorption combined with GC-MS (TD-GC-MS).
Śmiełowska M; Ligor T; Kupczyk W; Szeliga J; Jackowski M; Buszewski B
J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37406626
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy control by breath profile with application of SPME-GC/MS method.
Ulanowska A; Trawińska E; Sawrycki P; Buszewski B
J Sep Sci; 2012 Nov; 35(21):2908-13. PubMed ID: 23001965
[TBL] [Abstract][Full Text] [Related]
14. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics.
Rudnicka J; Kowalkowski T; Ligor T; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505
[TBL] [Abstract][Full Text] [Related]
15. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
16. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
18. Identification of a characteristic VOCs pattern in the exhaled breath of post-COVID subjects: are metabolic alterations induced by the infection still detectable?
Di Gilio A; Palmisani J; Picciariello A; Zambonin C; Aresta A; De Vietro N; Franchini SA; Ventrella G; Nisi MR; Licen S; Barbieri P; Altomare DF; de Gennaro G
J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37379826
[TBL] [Abstract][Full Text] [Related]
19. Multimodal chemometric approach for the analysis of human exhaled breath in lung cancer patients by TD-GC × GC-TOFMS.
Pesesse R; Stefanuto PH; Schleich F; Louis R; Focant JF
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1114-1115():146-153. PubMed ID: 30745111
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive meta-analysis and systematic review of breath analysis in detection of COVID-19 through Volatile organic compounds.
Long GA; Xu Q; Sunkara J; Woodbury R; Brown K; Huang JJ; Xie Z; Chen X; Fu XA; Huang J
Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116309. PubMed ID: 38692202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
